Coffee Consumption, Gender, and Parkinson’s Disease Mortality in the Cancer Prevention Study II Cohort: The Modifying Effects of Estrogen

Ascherio, A.·2004·American Journal of Epidemiology
DOI 10.1093/aje/kwh312

Cited by (232)

Items 101–200 of 232

  1. Elemental analysis of Brazilian coffee with ion beam techniques: From ground coffee to the final beverage
    Rafaela Debastiani, Carla Eliete Iochims dos Santos, Mateus Maciel Ramos, Vanessa Sobrosa Souza, L. Amaral, Maria Lucia Yoneama, Johnny Ferraz Dias · 2019 · Food Research International
  2. Consumption of green coffee and the risk of chronic diseases
    Nevin Şanlıer, Azize Atik, İlker Atik · 2018 · Critical Reviews in Food Science and Nutrition
  3. The Impact of Coffee and Caffeine on Multiple Sclerosis Compared to Other Neurodegenerative Diseases
    Lena Herden, Robert Weissert · 2018 · Frontiers in Nutrition
  4. Coffee Consumption Is Associated with DNA Methylation Levels of Human Blood
    Chuang, Yu-Hsuan, Quach, Austin, Absher, Devin, Assimes, Themistocles, Horvath, Steve, Ritz, Beate · 2017 · European Journal of Human Genetics
  5. Newly Approved and Investigational Drugs for Motor Symptom Control in Parkinson's Disease
    Daniel G. Di Luca, Nikolai Gil D. Reyes, Susan Helen Fox · 2022 · Drugs
  6. Reduction by coffee consumption of prostate cancer risk: Evidence from the Moli‐sani cohort and cellular models
    George Pounis, Claudio Tabolacci, Simona Costanzo, Martina Cordella, Marialaura Bonaccio, Livia Rago, Daniela D’Arcangelo, Augusto Filippo Di Castelnuovo, Giovanni de Gaetano, Maria Benedetta Donati et al. · 2017 · International Journal of Cancer
  7. NCEH-1 modulates cholesterol metabolism and protects against α-synuclein toxicity in a C. elegans model of Parkinson’s disease
    Siyuan Zhang, Samantha A. Glukhova, Kim A. Caldwell, Guy A. Caldwell · 2017 · Human Molecular Genetics
  8. The Confounded Relation of Coffee Drinking to Coronary Artery Disease
    Arthur L. Klatsky, Sheri Koplik, Harald Kipp, GARY D. FRIEDMAN · 2008 · The American Journal of Cardiology
  9. An exploratory study of serum creatinine levels in patients with amyotrophic lateral sclerosis
    Xueping Chen, Xiaoyan Guo, Rui Huang, Zhenzhen Zheng, Yongping Chen, Huifang Shang · 2014 · Neurological Sciences
  10. Evaluation of fungal contamination and ochratoxin A detection in different types of coffee by HPLC‐based method
    Keyvan Pakshir, Andishe Dehghani, Hasti Nouraei, Zahra Zareshahrabadi, Kamiar Zomorodian · 2021 · Journal of Clinical Laboratory Analysis
  11. Caffeine and Activation Theory
    2006 · CRC Press eBooks
  12. Lifestyle, Family History, and Risk of Idiopathic Parkinson Disease: A Large Danish Case-Control Study
    Line Kenborg, Christina Funch Lassen, Beate R. Ritz, Klaus K. Andersen, Jane Christensen, Eva S. Schernhammer, Johnni Hansen, Lene Wermuth, Naja Hulvej Rod, Jørgen H. Olsen · 2015 · American Journal of Epidemiology
  13. Silver nanoparticles and electrochemically reduced graphene oxide nanocomposite based biosensor for determining the effect of caffeine on Estradiol release in women of child-bearing age
    Mamta Raj, Rajendra N. Goyal · 2019 · Sensors and Actuators B Chemical
  14. Stored RBC metabolism as a function of caffeine levels
    Angelo D’Alessandro, Xiaoyun Fu, Julie A. Reisz, Tamir Kanias, Grier P. Page, Mars Stone, Steven H Kleinman, James C. Zimring, Michael Paul Busch, for the Recipient Epidemiology and Donor Evaluation Study‐III (REDS III) · 2020 · Transfusion
  15. Risk of Parkinson's disease after tamoxifen treatment
    Jeanne C. Latourelle, Merete Dybdahl, Anita L. DeStefano, Richard H. Myers, Timothy Lee Lash · 2010 · BMC Neurology
  16. Hormone replacement therapy and Parkinson’s disease risk in women: a meta-analysis of 14 observational studies
    Jichen Du, Peifu Wang, Jing Li, Shi Qiu, Honfeng Wen · 2014 · Neuropsychiatric Disease and Treatment
  17. Estrogen-mediated neuroprotection in the cortex may require NMDA receptor activation.
    B. J. Connell, K. Crosby, M. J. Richard, M. Mayne, T. Saleh · 2007 · Neuroscience
  18. Reproductive factors and Parkinson's disease risk in Danish women
    Naomi Greene, Christina Funch Lassen, Kathrine Rugbjerg, Beate R. Ritz · 2014 · European Journal of Neurology
  19. A Meta-Analysis of Coffee Intake and Risk of Urolithiasis
    Shuai Wang, Yuelong Zhang, Zujie Mao, Xiang He, Qi Zhang, Dahong Zhang · 2014 · Urologia Internationalis
  20. Parkinson's disease: the nutrition perspective
    Mícheál Ó Breasail, Matthew D. Smith, Emma Tenison, Emily J. Henderson, Fiona E. Lithander · 2021 · Proceedings of The Nutrition Society
  21. Some aspects of astroglial functions and aluminum implications for neurodegeneration
    David A. Aremu, Shunsuke Meshitsuka · 2006 · Brain Research Reviews
  22. Potential Role of Caffeine in the Treatment of Parkinson’s Disease
    Mohsin H. K. Roshan, Amos Tambo, Nikolai Paul Pace · 2016 · The Open Neurology Journal
  23. Coffee reduces KRAS expression in Caco-2 human colon carcinoma cells via regulation of miRNAs
    Takuya Nakayama, Megumi Funakoshi‐Tago, Hiroomi Tamura · 2017 · Oncology Letters
  24. The Changing Landscape of Parkinson Epidemiologic Research
    Honglei Chen · 2017 · Journal of Parkinson s Disease
  25. The complexities of hormonal influences and risk of Parkinson's disease
    Connie Marras, Rachel J. Saunders-Pullman · 2014 · Movement Disorders
  26. Effect of heat treatment on the content of individual phospholipids in coffee beans
    Li Yan Zhou, Ali Khalil, Françoise Bindler, Minjie Zhao, Christophe Marcic, Saïd Ennahar, Eric Marchioni · 2013 · Food Chemistry
  27. Interaction between caffeine and polymorphisms of glutamate ionotropic receptor NMDA type subunit 2A (GRIN2A) and cytochrome P450 1A2 (CYP1A2) on Parkinson's disease risk
    Iris Y. Kim, Éilis J. O’Reilly, Katherine C. Hughes, Xiang Gao, Michael A. Schwarzschild, Marjorie L. McCullough, Marian T. Hannan, Rebecca A. Betensky, Alberto Ascherio · 2018 · Movement Disorders
  28. Caffeine Stimulates Cytochrome Oxidase Expression and Activity in the Striatum in a Sexually Dimorphic Manner
    Frederick Scheetz Jones, Jie Jing, Anthony H. Stonehouse, Anthony Stevens, Gerald M. Edelman · 2008 · Molecular Pharmacology
  29. Trend tests for the evaluation of exposure-response relationships in epidemiological exposure studies
    Ludwig A. Hothorn, Michael Væth, Torsten Hothorn · 2009 · Epidemiologic Perspectives & Innovations
  30. Distinct sensitivity to caffeine-induced insomnia related to age
    Júlia Frozi, Hudson W. de Carvalho, Gustavo L. Ottoni, Rodrigo Antunes Cunha, Diogo Rizzato Lara · 2017 · Journal of Psychopharmacology
  31. A review of diagnostic imaging approaches to assessing Parkinson's disease
    Ethan Samson, Michael D. Noseworthy · 2022 · Brain Disorders
  32. LRRK2 G2385R variant carriers of female Parkinson’s disease are more susceptible to motor fluctuation
    Chao Gao, Hao Pang, Xiaoguang Luo, Yan Ren, Hong Shang, Zhiyi He · 2013 · Journal of Neurology
  33. How does caffeine influence memory? Drug, experimental, and demographic factors
    Ruo-Chong Zhang, Christopher R. Madan · 2021 · Neuroscience & Biobehavioral Reviews
  34. Luxembourg Parkinson’s study -comprehensive baseline analysis of Parkinson’s disease and atypical parkinsonism
    Lukas Pavelka, Rajesh Rawal, Soumyabrata Ghosh, Claire Pauly, Laure Pauly, Anne-Marie Hanff, Pierre Luc Kolber, Sonja R. Jónsdóttir, Deborah McIntyre, Kheira Azaiz et al. · 2023 · Frontiers in Neurology
  35. Differences in Parkinson’s Disease Risk with Caffeine Intake and Postmenopausal Hormone Use
    Iris Y. Kim, Éilis J. O’Reilly, Katherine C. Hughes, Xiang Gao, Michael A. Schwarzschild, Alberto Ascherio · 2017 · Journal of Parkinson s Disease
  36. Parkinson's Disease: Genetics and Pathogenesis
    Claudia M. Testa · 2007 · Wiley eBooks
  37. Effect of Acute Caffeine Supplementation on Anaerobic Power and Blood Lactate Levels in Female Athletes
    Reza Mahdavi, S. Daneghian, A. Jafari, A. Homayouni · 2015 · Journal of Caffeine Research
  38. Coffee and green tea consumption and subsequent risk of acute myeloid leukemia and myelodysplastic syndromes in Japan
    Tomotaka Ugai, Keitaro Matsuo, Norie Sawada, Motoki Iwasaki, Taiki Yamaji, Taichi Shimazu, Atsushi Goto, Manami Inoue, Yoshinobu Kanda, Shoichiro Tsugane · 2017 · International Journal of Cancer
  39. Systematic target function annotation of human transcription factors
    Yong Fuga Li, Russ Biagio Altman · 2018 · BMC Biology
  40. Epigenetic modifications induced by exercise: Drug-free intervention to improve cognitive deficits associated with obesity
    Leonardo Barros, Tuany Eichwald, Alexandre Francisco Solano, Débora da Luz Scheffer, Rodrigo A. da Silva, Joana Margarida Gaspar, Alexandra Latini · 2019 · Physiology & Behavior
  41. Gender-dependent effect of coffee consumption on tremor severity in de novo Parkinson’s disease
    Bang‐Hoon Cho, Seong‐Min Choi, Byeong Chae Kim · 2019 · BMC Neurology
  42. Association of urinary caffeine and caffeine metabolites with cardiovascular disease risk in adults
    Zhenkun Weng, Cheng Xu, Jin Xu, Zhaoyan Jiang, Qian Liu, Jingjia Liang, Aihua Gu · 2020 · Nutrition
  43. Smoking exposure and Parkinson's disease: A UK Brain Bank pathology-validated case-control study
    Lazzaro di Biase, Pasquale Maria Pecoraro, Simona Paola Carbone, Francesca Alessi, Vincenzo Di Lazzaro · 2024 · Parkinsonism & Related Disorders
  44. Movement Disorders in Women
    J. Baker, Albert Y. Hung · 2017 · Seminars in Neurology
  45. La cafeína como un fármaco preventivo de la enfermedad de Parkinson: evidencias epidemiológicas y sustrato experimental
    José Luis Góngora-Alfaro · 2010 · Revista de Neurología
  46. Recent Studies on Nutrition and Parkinson’s Disease Prevention: A Systematic Review
    Ann Gaba · 2015 · Open Journal of Preventive Medicine
  47. Deep brain stimulation of the subthalamic nucleus in Parkinson's disease 2003–2013: Where are we another 10 years on?
    Alexander Alamri, Ismail Ughratdar, Michael Samuel, Keyoumars Ashkan · 2015 · British Journal of Neurosurgery
  48. Cigarette smoking, coffee intake and alcohol consumption preceding Parkinson's disease: a case–control study
    Sandra Šipetić Grujičić, Hristina Vlajinac, Jadranka M. Maksimovic, Jelena Marinković, Eleonora D. Dzoljic, Isidora Ratkov, V.S. Kostić · 2011 · Acta Neuropsychiatrica
  49. Phytochemical regulation of Fyn and AMPK signaling circuitry
    Chan Gyu Lee, Ja Hyun Koo, Sang Geon Kim · 2015 · Archives of Pharmacal Research
  50. Australian Parkinson’s Genetics Study (APGS): pilot (n=1532)
    Svetlana Bivol, George D. Mellick, Jacob Gratten, Richard Parker, Aoibhe Mulcahy, Philip E. Mosley, Peter C. Poortvliet, Adrián I. Campos, Brittany L. Mitchell, Luis M. García‐Marín et al. · 2022 · BMJ Open
  51. Long-lasting resistance to haloperidol-induced catalepsy in male rats chronically treated with caffeine
    José Luis Góngora-Alfaro, Rosa Esther Moo-Puc, Jairo R. Villanueva-Toledo, Fernando J. Álvarez-Cervera, José L. Bata-García, Francisco J. Heredia-López, Juan Carlos Pineda · 2009 · Neuroscience Letters
  52. Association Between Menopausal Hormone Therapy and Risk for Parkinson’s Disease
    Jin‐Sung Yuk, Seong Ho Jeong · 2023 · Journal of Parkinson s Disease
  53. Interaction between caffeine consumption & genetic susceptibility in Parkinson’s disease: A systematic review
    Yujuan Yang, Zhidong Zhou, Ling Yi, Brendan Jen‐Wei Tan, Eng-King Tan · 2024 · Ageing Research Reviews
  54. Role of Adenosine A 2A Receptors in the Central Fatigue of Neurodegenerative Diseases
    Ana Cristina de Bem Alves, Viviane José de Oliveira Bristot, Mirieli Denardi Limana, Ana Elisa Speck, Leonardo Barros, Alexandre Francisco Solano, Aderbal S. Aguiar · 2019 · Journal of Caffeine and Adenosine Research
  55. Metabolic study of cafestol using in silico approach, zebrafish water tank experiments and liquid chromatography high-resolution mass spectrometry analyses
    Cyrus Veiga Andriolo, Fábio Júnior Moreira Novaes, Henrique Marcelo Gualberto Pereira, Vinícius Figueiredo Sardela, Cláudia M. Rezende · 2021 · Journal of Chromatography B
  56. Coffee and Caffeine Intake among Students of the Brazilian Northeast
    Andreza M. Penafort, Isabella Barbosa Pereira, Antônio Augusto Ferreira Carioca, Maria Olganê Dantas Sabry, Francisco José Maia Pinto, Helena Alves de Carvalho Sampaio · 2016 · Food and Nutrition Sciences
  57. Analysis of Y chromosome haplogroups in Parkinson’s disease
    Francis P. Grenn, Mary B. Makarious, Sara Bandrés‐Ciga, Hirotaka Iwaki, Andrew Singleton, Mike A. Nalls, Cornelis Blauwendraat · 2022 · Brain Communications
  58. Coffee, Genetic Variants, and Parkinson's Disease: Gene–Environment Interactions
    Naomi Yamada-Fowler, Peter Söderkvist · 2015 · Journal of Caffeine Research
  59. Premature or pathological aging: longevity
    Valdemiro Carlos Sgarbieri, Maria Teresa Bertoldo Pacheco · 2017 · Brazilian journal of food technology/Brazilian Journal of Food Technology
  60. Neuroactive β-Carbolines Norharman and Harman in Coffee
    Susana I.P. Casal · 2014 · Coffee in Health and Disease Prevention
  61. The role of genetics and gender specific differences in neurodegenerative disorders: Insights from molecular and immune landscape
    Shahnaz Hosseinzadeh, Salva Afshari, Soheila Molaei, Nima Rezaei, Masoomeh Dadkhah · 2023 · Journal of Neuroimmunology
  62. Relationships between plasma levels of nitrogenous metabolites and some psycho-neuro-endocrine parameters
    Igor Bombushkar, А. І. Гоженко, Mykhaylo Korda, Xawery Żukow, Igor L. Popovych · 2022 · Journal of Education Health and Sport
  63. Does Drinking Coffee Reduce the Incidence of Parkinson's Disease?
    Tsz Ki Ko · 2023 · Cureus
  64. Clinical evidence linking coffee and tea intake with Parkinson’s disease
    Kumar Manharlal Prakash, Eng‐King Tan · 2011 · Basal Ganglia
  65. Urine caffeine metabolites are positively associated with cognitive performance in older adults: An analysis of US National Health and Nutrition Examination Survey (NHANES) 2011 to 2014
    Di Liu, Fengfei Xie, Nimei Zeng, Renfang Han, Deli Cao, Zengli Yu, Yun Wang, Zhongxiao Wan · 2022 · Nutrition Research
  66. Etiology and pathogenesis of Parkinson disease
    Joseph J. Jankovic, Mark Hallett, Michael S. Okun, Cynthia Comella, Stanley Fahn, Jennifer G. Goldman · 2021 · Elsevier eBooks
  67. Real-time screening of melamine in coffee capsules using infrared thermography and deep learning
    Natalia Hernansanz Luque, Ana M. Pérez-Calabuig, Sandra Pradana‐López, John C. Cancilla, José S. Torrecilla · 2025 · Journal of Food Engineering
  68. Epidemiologic Risk and Prevention and Interventions in Parkinson Disease: From a Nutrition-Based Perspective
    Fan Zhang, Yuxian Liu, Yun Zhu, Qiu-Yan Yu, Samwel Sylvester Msigwa, Zhi-Hai Zeng, Xiong Zhang, Hong-Mei Wu, Jian‐Hong Zhu · 2025 · Journal of Nutrition
  69. Analytical approaches used in the profiling of natural products with a therapeutic target: a global perspective on nutrition and health
    Najla Bentrad, Asma Hamida-Ferhat · 2022 · Studies in natural products chemistry
  70. CAFFEINE AND CHLOROGENIC ACIDS IN COFFEE AND EFFECTS ON SELECTED NEURODEGENERATIVE DISEASES
    Roseane Maria Maia Santos, Tracy Hunter, Nick Wright, Darcy Roberto Andrade Lima · 2013 · Journal of Pharmaceutical and Scientific Innovation
  71. Coffee and Cancers
    André Nkondjock · 2012 · Wiley eBooks
  72. Coffee consumption and all-cause and cardiovascular mortality in older adults: should we consider cognitive function?
    Fabin Lin, Yisen Shi, Xinyang Zou, Huaicheng Wang, Shibo Fu, Xuefei Wang, Zeqiang Yang, Guofa Cai, Guoen Cai, Xilin Wu · 2023 · Frontiers in Nutrition
  73. Effects of Caffeine Supplementation on Oxidative Stress, Exercise-Induced Muscle Damage and Leukocytosis
    Reza Mahdavi, Sevana Daneghian, Aziz Homayouni Rad, Afshar Jafari · 2013 · Pharmaceutical Sciences
  74. Koffein: hagyományos és új terápiás indikációk, valamint felhasználás dermatológiai modellvegyületként
    Luca Anna Bors, Ágnes Bajza, Dorottya Kocsis, Franciska Erdő · 2018 · Orvosi Hetilap
  75. Current concepts on the etiology and pathogenesis of Parkinson disease
    Stanley Fahn, Joseph J. Jankovic, Mark Hallett · 2011 · Elsevier eBooks
  76. Caffeine, nicotine, cannabis, and psilocybin: Pharmacology, toxicology, and potential therapeutic uses of four naturally occurring psychoactive substances
    Samuel E Christen, Elias Bekka, Yasmin Schmid, Neal L. Benowitz, Evangelia Liakoni · 2025 · Swiss Medical Weekly
  77. Koffein, Schokolade und Adenosin A2A Rezeptorantagonisten in der Behandlung des Parkinson Syndroms
    Heinz Reichmann · 2022 · Fortschritte der Neurologie · Psychiatrie
  78. Use of Herbal Products/Alternative Medicines in Neurodegenerative Diseases (Alzheimer’s Disease and Parkinson’s Disease)
    Omar M. E. Abdel‐Salam · 2018 · Springer eBooks
  79. Coffee and Parkinson's Disease
    Jing Wei Lim, Eng‐King Tan · 2012 · Wiley eBooks
  80. Coffee and Health
    Gary Williamson · 2011 · Wiley eBooks
  81. Anti-inflammatory Activities of Cold Brew Coffee Using Dry Fermentation of Lactobacillus plantarum
    Seok Hyeon Go, Chaiwat Monmai, A-yeong Jang, Hyungjae Lee, Woo Jung Park · 2018 · Food Engineering Progress
  82. Herbal Drugs: Its Mechanism to Prevent Alzheimer’s Disease with Special Reference to Non-phenolic Secondary Metabolites
    Ratnam V. Kamsala, Lepakshi Md. Bhakshu, Rudraraju Reddi Venkataraju · 2022 · Nutritional neurosciences
  83. Controlled Coffee Intake Enhances Erythrocyte Deformability, Na,K-ATPase Activity, and GSH/GSSG Ratio in Healthy Young Adults
    Dominika Radošinská, Tomáš Jasenovec, Alzbeta Golianova, Ivan Szadvári, Rastislav Vazan, Ivona Kovačičová, Denisa Snurikova, Norbert Vrbjar, Jana Radošinská · 2024 · Biomedicines
  84. Sexual dimorphism in relationships between of plasma uric acid and some psycho-neuro-endocrine parameters
    Igor Bombushkar, Mykhaylo Korda, Xawery Żukow, Igor L. Popovych · 2022 · Journal of Education Health and Sport
  85. Pharmacological strategies for Parkinson’s disease
    José-Rubén García-Montes, Alejandra Boronat-García, René Drucker-Colı́n · 2012 · Health
  86. Levels of caffeine and its metabolites among U.S. smokers and nonsmokers
    Ram Baboo Jain · 2015 · Environmental Toxicology and Pharmacology
  87. Can dietary substances protect against Parkinson's disease? The case of caffeine
    Micaela Morelli, Nicola Simola · 2010 · Experimental Neurology
  88. Pharmacological Properties and Neurophsysiological Effects of Caffeine
    Astrid Nehlig · 2006 · CRC Press eBooks
  89. Coffee: All You Need to Know
    Natasha Ijaz, Maryam Sardar, Hafiza Sana Mehak · 2021 · FRONTIERS IN CHEMICAL SCIENCES
  90. The Story of “Speed” from “Cloud Nine” to Brain Gain
    Andrew John Lees, Katrin Sikk, Pille Taba · 2015 · International review of neurobiology
  91. A Role of β2-Adrenoreceptor Agonists Related to the Development of Parkinson's Disease
    Dain Jung, Do Won Kwak, Minki Kim, Woong‐Woo Lee · 2023 · Neurology India
  92. Caffeine and Neuroprotection in Parkinson’s Disease
    Filipe Brogueira Rodrigues, Daniel Caldeira, Joaquim José Ferreira, João Guilherme Costa · 2015 · Current topics in neurotoxicity
  93. Aspekte der Ernährung zur Prävention und Therapie chronisch neurologischer Erkrankungen
    Verena Isabell Leussink · 2019 · Der Nervenarzt
  94. Epidemiology
    Raymond Y. Lo, Caroline M. Tanner · 2013 · Informa Healthcare eBooks
  95. Green Coffee Bean Extract and Chlorogenic Acids: Chemistry and Novel Antioxidant Benefits
    2016 · CRC Press eBooks
  96. Amphetamine-induced dopaminergic toxicity:
    Jobes, Michelle L. · 2008 · Rutgers University Community Repository (Rutgers University)
  97. Coffee and Risk of Type 2 Diabetes
    Siamak Bidel, J. Tuomilehto · 2007 · Työväentutkimus Vuosikirja
  98. Estudio caso-control en búsqueda de una asociación entre el consumo de yerba mate y la enfermedad de Parkinson (datos preliminares)
    Carlos Mario Melcon, Leonardo C. Bartoloni, Virginia Laura Parisi, Claudio Daniel González, Nélida Garretto, Tomoko Arakaki, Hernán Pavón, José A. Bueri, Marcelo Mattiazzi, Emilia Mabel Gatto · 2014 · Neurología Argentina
  99. Coffee and the Risk of Dementia and Cognitive Impairment
    Rebecca P. Gelber, Lon R. White · 2014 · Elsevier eBooks
  100. Evaluation of the Effect of Roasted Constituents on the Antioxidant Activity of Cereal Coffee
    Dorota Klensporf‐Pawlik, Małgorzata Anna Majcher, Katarzyna Frąckowiak · 2017 · Towaroznawcze Problemy Jakości. Polskie Towarzystwo Towaroznawcze